Moradabad no longer polio epicentre: study

Mumbai-based Enterovius Research Centre — a WHO accredited global specialised laboratory for polio, located at Haffkine Institute campus — undertook the study in association with the Indian Council of Medical Research and other health agencies, in November at Moradabad to assess the immunity levels of children in two age groups — six to 12 months and three to five years.

Dr J M Deshpande, Director of ERV, said a sample size of 900 children — who had been exposed to routine and supplementary rounds of immunisation — was studied. At least 99 per cent of children in the age group of three to five years had antibodies against the P-1 virus, while 90 per cent of the children in the age group of six to 12 months — who had received four doses of the high potency vaccine, monovalent oral polio vaccine (mOPV-1) — had antibodies against the Type 1 (P-1), the most virulent form of polio virus.

Following global concern over polio revival in western UP in 2006, the Government had stepped up its efforts with successive immunisation rounds. In 2006, 269 out of the 297 cases of polio were from UP and 80 per cent of the cases were from Moradabad, JP Nagar, Bareilly, Badaun, Rampur, Muzaffarnagar, Meerut and Bulandshahr districts.

Once the Union Health Ministry declared that there was not a single case of P-1 in western UP, the study was initiated last year to examine how effective the mOPV1 vaccine was in dealing with the virus. The health officials had ensured that the quality rounds were sustained in 2007, so that there would be a minimum number of missing children. Unlike other states where the polio immunisation coverage is 80 per cent of the estimated target of children, it is only 40...